|
Quinton Cardiology Systems |
|
|
3303 Monte Villa Parkway Bothell, WA 98021 USA phone:1.425.402.2000 fax:1.425.402.2001
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.quinton.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Diagnostic cardiology systems. |
 |
| Management |
| Ruediger Naumann-Etienne, Ph.D., Chairman; John R. Hinson, President and CEO; Michael K. Matysik, Senior Vice President, CFO and Secretary; Atul Jhalani, VP of Marketing |
| |
|
|
| |
|
| Keywords |
| electrocardiographs, Cardiology, cardiac, heart, monitoring, diagnostics, ecg |
|
|
|
| Description |
|
On September 1, 2005, Quinton Cardiology Systems, Inc. and Cardiac Science, Inc., merged to form Cardiac Science Corporation. Shares of the new corporation are traded on the Nasdaq National Market under the symbol CSCX.
Quinton Cardiology Systems, Inc. develops, manufactures, markets and services a family of diagnostic cardiology systems used in the diagnosis, treatment and rehabilitation of patients with heart disease. |
 |
| Products / Services |
The Company's products include electrocardiographs (ECGs), stress test systems, Holter monitoring systems, cardiac catheterization management systems, cardiac rehabilitation telemetry systems, ECG management systems, medical treadmills and patented electrodes. The Company also sells other consumables related to its products.
|
 |
 |
|
|
|
|
|
|